Figure 3.

Forest plots of nucleos(t)ide analogue studies: subgroup analysis on the incidence of LTCs in patients with drug-resistance between NA treatment and no treatment. Liaw et al * (Figure 3, Figure 4 and Figure 5):two patients had evidence of YMDD mutations at baseline and five patients no samples after baseline, so data on the emergence of YMDD mutations during therapy were available for 644 patients[23].

Zhang et al. Virology Journal 2011 8:72   doi:10.1186/1743-422X-8-72
Download authors' original image